These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2567049)

  • 21. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation.
    Manthorpe R; Hørbov S; Sylvest J; Vinterberg H
    Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
    Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
    Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective five-year comparison of treatment which included penicillamine with that excluding penicillamine in early rheumatoid arthritis. The Multicentre Trial Group.
    Br J Rheumatol; 1986 May; 25(2):184-92. PubMed ID: 2871887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
    Borg AA; Davis MJ; Dawes PT; Shadforth MF
    Clin Rheumatol; 1994 Sep; 13(3):522-4. PubMed ID: 7835022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies with salazopyrine--consequences and perspectives].
    Zeidler H
    Z Rheumatol; 1987; 46(2):59-66. PubMed ID: 2885985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of second line therapy in rheumatoid arthritis.
    Porter DR; McInnes I; Hunter J; Capell HA
    Ann Rheum Dis; 1994 Dec; 53(12):812-5. PubMed ID: 7864689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the progression of joint damage in rheumatoid arthritis.
    Scott DL; Farr M
    Drugs; 1986; 32 Suppl 1():63-70. PubMed ID: 2877856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penicillamine for rheumatoid arthritis.
    Suarez-Almazor ME; Spooner C; Belseck E
    Cochrane Database Syst Rev; 2000; 2000(2):CD001460. PubMed ID: 10796440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial of penicillamine in rheumatoid arthritis.
    Rothermich NO; Thomas MH; Phillips VK; Bergen W
    Arthritis Rheum; 1981 Dec; 24(12):1473-8. PubMed ID: 7034736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
    Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
    Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?
    Capell HA; Porter DR; Madhok R; Hunter JA
    Ann Rheum Dis; 1993 Jun; 52(6):423-8. PubMed ID: 8100702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.
    van der Heijde DM; van Riel PL; Nuver-Zwart IH; Gribnau FW; vad de Putte LB
    Lancet; 1989 May; 1(8646):1036-8. PubMed ID: 2565997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis.
    Bunch TW; O'Duffy JD; Tompkins RB; O'Fallon WM
    Arthritis Rheum; 1984 Mar; 27(3):267-76. PubMed ID: 6367750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.
    Berry H; Fernandes L; Ford-Hutchinson AW; Evans SJ; Hamilton EB
    Ann Rheum Dis; 1978 Feb; 37(1):93-7. PubMed ID: 24426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.
    Bax DE; Greaves MS; Amos RS
    Br J Rheumatol; 1986 Aug; 25(3):282-4. PubMed ID: 2873862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.